TickerFacts.

Jyong Biotech Ltd. (MENS): Total Assets

Annual figures by period end, from SEC filings.

$20.78M
As of 2025-12-31
2024-12-31: $6.37M2025-12-31: $20.78M$20.78M
2024-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$20.78M+226.4%2026-05-15, Balance as of period end
2024-12-31$6.37Mn/a2026-05-15, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Jyong Biotech Ltd. (MENS)2025-12-31$20.78M+226.4%
Abvc Biopharma, Inc. (ABVC)2025-12-31$21.06M+179.3%
Annovis Bio, Inc. (ANVS)2025-12-31$21.08M+51.4%
Incannex Healthcare Inc. (IXHL)2025-06-30$20.45M+19.9%
Nexentis Technologies Inc. (NXTS)2025-12-31$20.41M+273.4%
Quoin Pharmaceuticals Ltd. (QNRX)2025-12-31$20.39M+29.8%
Evofem Biosciences, Inc. (EVFM)2025-12-31$20.27M-14.8%
Emmaus Life Sciences, Inc. (EMMA)2025-12-31$21.44M-9.2%
Phio Pharmaceuticals Corp. (PHIO)2025-12-31$21.49M+274.5%

Compare MENS, ABVC, ANVS, IXHL side by side · Screen every company in Pharmaceutical Preparations ↗